NovoCure Ltd — Director's Dealing 2019

Feb 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-02-01

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-01	Ordinary Shares	M	37500	$7.15	Acquired	184058	Direct
2019-02-01	Ordinary Shares	S	27660	$48.861	Disposed	156398	Direct
2019-02-01	Ordinary Shares	S	9840	$49.508	Disposed	146558	Direct
2019-02-04	Ordinary Shares	M	21000	$7.15	Acquired	167558	Direct
2019-02-04	Ordinary Shares	S	21000	$49.533	Disposed	146558	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-01	Options to Buy Ordinary Shares	$7.15	M	37500	Disposed	2027-02-21	Ordinary Shares (37500)	Direct
2019-02-04	Options to Buy Ordinary Shares	$7.15	M	21000	Disposed	2027-02-21	Ordinary Shares (21000)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi.

F2: On February 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 27,660 shares in multiple trades at prices ranging from $48.33 to $49.32. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On February 1, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 9,840 shares in multiple trades at prices ranging from $49.33 to $49.94. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: On February 4, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 21,000 shares in multiple trades at prices ranging from $49.08 to $49.75. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F5: Fully vested as of the date hereof.